A Mercaptoacetamide-Based Class II Histone Deacetylase Inhibitor Increases Dendritic Spine Density via RasGRF1/ERK Pathway. [electronic resource]
Producer: 20161220Description: 591-604 p. digitalISSN:- 1875-8908
- Acetamides -- pharmacology
- Animals
- Blotting, Western
- Cells, Cultured
- Cerebral Cortex -- cytology
- Dendritic Spines -- drug effects
- Gene Knockdown Techniques
- Green Fluorescent Proteins -- genetics
- Hippocampus -- cytology
- Histone Deacetylase Inhibitors -- pharmacology
- Immunohistochemistry
- MAP Kinase Signaling System -- drug effects
- Mice, Inbred C57BL
- RNA, Messenger -- metabolism
- Rats, Sprague-Dawley
- Real-Time Polymerase Chain Reaction
- Receptors, AMPA -- metabolism
- Receptors, N-Methyl-D-Aspartate -- metabolism
- Thioglycolates -- pharmacology
- Transfection
- ras-GRF1 -- genetics
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.